The 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy took place with great success on 9-12 of March 2016, at Athens, Greece. The very latest on Alzheimer therapy were discussed by the very top leaders in the world and it was the very best opportunity to learn and interact in a welcoming scientific environment. Leading scientists discussed new targets and drugs for the treatment of Alzheimer’s disease and novel approaches to current therapy.
The Highlights of the Congress are available.
NTUA presentations concerned:
Association between motor ability tasks and driving parameters in healthy, patients with mild cognitive impairment (MCI) and mild Alzheimer’s disease (AD)
Mini Mental State Examination and Montreal Cognitive Assessment: which is the best predictor of Driving Ability?
Self-assessment of driving performance in patients with Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD)
Mild Cognitive Impairment: The role of in-vehicle distraction in driving behavior